Skip to main content
Year archive

CYNATA THERAPEUTICS LIMITED — 2018 filings

All 87 regulatory filings released by CYNATA THERAPEUTICS LIMITED (CYP) in 2018, sourced directly from the official regulator.

87 Filings
2018 Period
2018 filings (87)
Filing Released Lang
End of Year Newsletter 6 pages 355.7KB
Investor Presentation
2018-12-19 English
Cynata Completes Clinical Study Report in GvHD 2 pages 189.3KB
Regulatory Filings
2018-12-17 English
NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs 2 pages 220.3KB
Regulatory Filings
2018-12-12 English
Cynata Receives $1.3m R&D Tax Incentive Refund 1 pa
Capital/Financing Update
2018-11-18 English
Annual General Meeting Presentation 45 pages 1.9MB
AGM Information
2018-11-14 English
Chairman's AGM Address 2 pages 142.9KB
AGM Information
2018-11-14 English
Results of Annual General Meeting 2 pages 203.2KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-14 English
Replacement-Results of Annual General Meeting 2 pages 191.7KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-14 English
CYP Receives Notice of Allowance from European Patent Office 2 pages 191.9KB
Regulatory Filings
2018-11-06 English
Cynata Clinical Trial Data Accepted for presentation at ASH 2 pages 180.0KB
Regulatory Filings
2018-11-01 English
Cyanta Outlook and Investor Presentation 45 pages 2.2MB
Investor Presentation
2018-10-31 English
Appendix 3Y-Dr Paul Wotton 2 pages 27.0KB
Director's Dealing
2018-10-25 English
September 2018 Quarterly Report 9 pages 370.3KB
Interim / Quarterly Report
2018-10-22 English
MSCs Demonstrate Anti-Cancer Effects in Pre-Clinical Studies 2 pages 208.6KB
Regulatory Filings
2018-10-17 English
Notice of Annual General Meeting/Proxy Form 15 pages 907.6KB
AGM Information
2018-10-10 English
Annual Report to Shareholders 70 pages 1.1MB
Annual Report
2018-10-10 English
Notification of 2018 Annual General Meeting Date 1
AGM Information
2018-09-26 English
Appendix 3B-Exercise of Options 11 pages 198.2KB
Share Issue/Capital Change
2018-09-24 English
Cleansing Notice 1 page 114.4KB
Capital/Financing Update
2018-09-24 English
Appendix 3Y-Dr Paul Wotton 2 pages 27.4KB
Director's Dealing
2018-09-24 English
Appendix 3Y-Dr Ross Macdonald 2 pages 27.8KB
Director's Dealing
2018-09-24 English
Appendix 3Y-Dr Stewart Washer 2 pages 27.3KB
Director's Dealing
2018-09-24 English
Cynata MSCs Ameliorate CRS in Preclinical Study 2 pages 210.9KB
Capital/Financing Update
2018-09-18 English
Results of Meeitng 2 pages 190.4KB
Declaration of Voting Results & Voting Rights Announcements
2018-09-11 English
Director Loan Funded Shares-Voluntary Escrow Arrangement 1
Share Issue/Capital Change
2018-09-04 English
Cynata Advances to Official Meeting with Japanese PMDA 1
Regulatory Filings
2018-09-02 English
Cynata to Present at Rodman & Renshaw Investor Conference 17 pages 1.5MB
Investor Presentation
2018-08-30 English
Cynata GvHD Trial Meets all Safety & Efficacy Endpoints 3 pages 249.0KB
Regulatory Filings
2018-08-29 English
Updated Appendix 4G 9 pages 270.5KB
Governance Information
2018-08-23 English
Appendix 4E & Financial Statements 72 pages 1.1MB
Annual Report
2018-08-21 English
Appendix 4G 9 pages 191.6KB
Governance Information
2018-08-21 English
Notice of General Meeting/Proxy Form 15 pages 947.7KB
Proxy Solicitation & Information Statement
2018-08-09 English
Cymerus MSCs improve cardiac recovery in preclinical study 2 pages 211.5KB
Regulatory Filings
2018-07-30 English
Appendix 3B-Exercise of Options 11 pages 196.9KB
Share Issue/Capital Change
2018-07-15 English
Cleansing Notice 1 page 107.4KB
Share Issue/Capital Change
2018-07-15 English
June 2018 Quarterly Report 9 pages 327.2KB
Interim / Quarterly Report
2018-07-10 English
Appendix 3B-Exercise of Options 11 pages 196.6KB
Share Issue/Capital Change
2018-07-10 English
Cleansing Notice 1 page 107.0KB
Share Issue/Capital Change
2018-07-10 English
Appendix 3B-Exercise of Options 11 pages 196.0KB
Share Issue/Capital Change
2018-07-05 English
Cleansing Notice 1 page 107.2KB
Share Issue/Capital Change
2018-07-05 English
Cynata Enters Development Partnership with RCSI 3 pages 222.1KB
Regulatory Filings
2018-07-01 English
Product Development Program Update & Investor Presentation 26 pages 1.8MB
Investor Presentation
2018-06-25 English
Positive 28-day Clinical Trial Data in Cohort B 3 pages 225.7KB
Regulatory Filings
2018-06-20 English
Research Collaboration with UNSW for Coronary Artery Disease 2 pages 177.5KB
Regulatory Filings
2018-06-17 English
Positive 6-Month Data from Cohort 1 in Phase 1 Trial in GvHD 2 pages 185.9KB
Regulatory Filings
2018-06-11 English
Change in substantial holding 2 pages 279.5KB
Major Shareholding Notification
2018-06-06 English
Appendix 3B 11 pages 193.7KB
Capital/Financing Update
2018-06-03 English
Cleansing Notice 1 page 104.9KB
Share Issue/Capital Change
2018-06-03 English
Cynata's MSCs Effective in Model of Diabetic Wounds 3 pages 190.9KB
Regulatory Filings
2018-05-30 English
$5.2m placement of shares to Fidelity International 2 pages 169.5KB
Capital/Financing Update
2018-05-29 English
Trading Halt 2 pages 344.5KB
Capital/Financing Update
2018-05-27 English
Enrolment Completed in Cynata's Phase 1 Clinical Trial 2 pages 213.9KB
Regulatory Filings
2018-05-23 English
Appendix 3B-Exercise of Options 11 pages 196.8KB
Share Issue/Capital Change
2018-05-21 English
Cleansing Notice 1 page 107.2KB
Regulatory Filings
2018-05-21 English
Appendix 3B-Exercise of Options 11 pages 195.8KB
Share Issue/Capital Change
2018-05-14 English
Cleansing Notice 1 page 107.2KB
Share Issue/Capital Change
2018-05-14 English
Notice of Allowance from EPO for Patent Application 1
Regulatory Filings
2018-05-06 English
Becoming a substantial holder 3 pages 289.2KB
Major Shareholding Notification
2018-05-06 English
March 2018 Quarterly Report 9 pages 282.5KB
Interim / Quarterly Report
2018-04-26 English
Appendix 3B-Exercise of Options 11 pages 198.1KB
Capital/Financing Update
2018-04-23 English
Cleansing Notice 1 page 107.0KB
Regulatory Filings
2018-04-23 English
CYP Completes Patent Application related to CAR-T Therapy 1
Regulatory Filings
2018-04-19 English
Cyanta to Present at ARM Investor Day 1 page 193.6K
Regulatory Filings
2018-04-11 English
Further US Patent Granted for Cynata Cymerus Technology 1
Regulatory Filings
2018-04-10 English
Appendix 3B-Exercise of Options 11 pages 195.7KB
Share Issue/Capital Change
2018-04-03 English
Cleansing Notice 1 page 107.2KB
Share Issue/Capital Change
2018-04-03 English
FDA Grants Orphan Drug Designation to Cyanta for CYP-001 2 pages 210.8KB
Regulatory Filings
2018-03-27 English
Appendix 3B-Exercise of Options 11 pages 196.7KB
Share Issue/Capital Change
2018-03-27 English
Cleansing Notice 1 page 107.2KB
Share Issue/Capital Change
2018-03-27 English
Updated Top 20 Shareholders 2 pages 71.7KB
Major Shareholding Notification
2018-03-12 English
Appendix 3B-Exercise of Options 11 pages 195.5KB
Capital/Financing Update
2018-03-12 English
Cleansing Notice 1 page 107.7KB
Share Issue/Capital Change
2018-03-12 English
Shaw and Partners Updates Cynata Research Coverage 1
Regulatory Filings
2018-03-11 English
Response to ASX Aware Query 6 pages 259.8KB
Regulatory Filings
2018-02-27 English
Appendix 3B-Exercise of Options 11 pages 195.4KB
Share Issue/Capital Change
2018-02-27 English
Cleansing Notice 1 page 107.7KB
Capital/Financing Update
2018-02-27 English
Excellent Data from Final Preliminary Evaluation Period 3 pages 227.7KB
Regulatory Filings
2018-02-26 English
Appendix 4D & Half-Year Financial Statements 20 pages 570.2KB
Interim / Quarterly Report
2018-02-26 English
Cynata Engineered MSC Study Review Reveals Promising Results 2 pages 197.2KB
Regulatory Filings
2018-02-04 English
December 2017 Quarterly Report 8 pages 313.0KB
Interim / Quarterly Report
2018-01-29 English
Cynata Treats First Patient in Cohort B 2 pages 214.7KB
Regulatory Filings
2018-01-23 English
Lapse of Unlisted Options 1 page 106.1KB
Share Issue/Capital Change
2018-01-22 English
Cyanta & Celularity Inc Execute MOU 3 pages 217.7KB
Capital/Financing Update
2018-01-22 English
Trading Halt 2 pages 200.8KB
Regulatory Filings
2018-01-21 English
Encouraging Early Data-Cynata Clinical Trial Proceeds 3 pages 222.4KB
Regulatory Filings
2018-01-21 English
Interview with Cynata Co-Founder Professor Slukvin 4 pages 188.4KB
Regulatory Filings
2018-01-10 English
Release of Securities from Voluntary Escrow 1 page
Share Issue/Capital Change
2018-01-10 English